Breathonix has developed a breath test to detect COVID-19 within a minute in-situ (on-site), achieving an accuracy above 90% at a recent pilot clinical trial involving 180 patients.
Following a successful trial at the National Centre for Infectious Diseases (NCID), the company said on Thursday (Oct 29) that it is currently in discussions with the Health Ministry (MOH) to deploy its breathalyser tests in trials at public locations in the coming months.
“The test works by detecting Volatile Organic Compounds (VOCs) present in a person’s exhaled breath. Test results are delivered in less than 60 seconds. Testing is key to reopening economies. Scientists and researchers all over the world are racing against time. Airports, especially, will find such speedy test means to be useful as they embark …
Breathalyzer Presented to Singapore’s Minister of Transport Ong Ye Kung Read More »
Universities are hotbeds for ideas, where pioneering solutions that tackle society’s challenges are often seeded and even commercialised. It was exciting to see the good work being done in the National University of Singapore’s innovation hubs during my visit earlier this week. At the NUS Innovation 4.0 space, I met with some alumni of the …
Showcased to Singapore’s Minister of Education Lawrence Wong Read More »
With its proprietary breath sampling device and data analysis algorithms, their technology analyses one’s “exhaled breath”, which provides an extremely precise way to detect diseases by analysing volatile organic compounds (VOCs).
In particular, instead of swab tests, new breath analyser devices developed by the National University of Singapore’s Nanoscience and Nanotechnology Institute that can detect lung cancer and tuberculosis can be re-purposed for the mass screening of COVID-19 for real-time and on-site analysis.
Dr Jia said: “I thought I was going to end up as a research scientist, but NUS made me see the potential of converting my idea into an actual invention that can help save lives.”
Breathonix selected into JUMPstart (Joint University Medtech Program), a program that provides aspiring Medtech innovators with unprecedented access to resources at the three leading universities in Singapore, NUS, NTU and SUTD.
Breathonix won the sector winner of Medtech sector in SLINGSHOT competition 2019, selected out of more than 2400 global startups, securing an additional SGD50,000 in grant. SLINGSHOT is an annual international startup competition organized by Enterprise Singapore and Startup SG. It provides entrepreneurs with an international platform to profile themselves to corporates, industry veterans and …
Breathonix has successfully graduated from National University of Singapore’s 12-month long GRIP program and secured SGD100K funding from NUS Enterprise.
